Form D · Biotechnology
RealBio Technology, Inc.
Kalamazoo, MI · CIK 0001471357
Offering snapshot reported Oct 18, 2013 · SEC filing
- Reported sold
- $485K Offering amount: $1M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 11, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 18, 2013 | Initial | $484,750 | No comparison | 4 | SEC filing |
| Dec 4, 2009 | Amendment | $1,125,000 | $250,000vs Nov 13, 2009 | 6 | SEC filing |
| Nov 13, 2009 | Amendment | $875,000 | $225,000vs Sep 3, 2009 | 5 | SEC filing |
| Sep 3, 2009 | Initial | $650,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-204875
Source: Form D, filed Oct 18, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jack Ball | Director |
| Roy Cosan | Director |
| Gene Mc Kay | Director |
| Patrick G. Morand | Director |
| Paul Neeb | Director, Executive |
| John Trittschuh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4717 Campus Drive Suite 1500
Kalamazoo, MI, 49008
Kalamazoo, MI, 49008